← SynDRA
JNJ-10397049
SynDRA canonical compound SYN1949271 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
|---|
| Primary target(s) | HCRTR1 | HCRTR2 |
|---|
| Mechanism of action | orexin receptor antagonist |
|---|
All known targets
Mechanisms of action (all sources)
- orexin receptor antagonist
- HCRTR2 MODULATOR
Cross-references
Synonyms
- JNJ 10397049
- UNII-1B419P24AV
- CHEMBL359632
- 1B419P24AV
- N-(2,4-Dibromophenyl)-N'-[(4S,5S)-2,2-dimethyl-4-phenyl-1,3-dioxan-5-yl]-urea
- JNJ10397049
- SCHEMBL1818251
- GTPL1701
- MolPort-035-765-717
- ZINC3960325
- BDBM50412863
- AKOS024458089
- compound 9 [PMID: 15261275]
- 1-(2,4-Dibromophenyl)-3-((4S,5S)-2,2-dimethyl-4-phenyl-(1,3)dioxan-5-yl)urea
- Urea, N-(2,4-dibromophenyl)-N'-((4S,5S)-2,2-dimethyl-4-phenyl-1,3-dioxan-5-yl)-
- NCGC00379105-01
- KB-77996
- B5553
- J3.628.691A
Look up JNJ-10397049 in the interactive SynDRA portal →